About the Journal | Editorial Board | Instructions to Contributors | Submission & Review | Advertise with Us | Subscribe to E- Alerts
Sitemap | Feedback
Advanced search
Journal of Case Reports
Distinctive Motor Stereotypy in a 4-month-old Infant with Congenital CMV Infection
Dawood Tafti1, David Ahn2  
1Department of Radiology, San Antonio Military Medical Center, 3551 Roger Brooke Dr. JBSA-Fort Sam Houston, TX, United States. 78234; 2Department of Anesthesiology, Walter Reed National Military Medical Center, 104 Wood Rd, Bethesda, MD, United States. 20814.
Corresponding Author:
Dr. Dawood Tafti 
Email: dtafti121@gmail.com
Received: 11-JUL-2020 Accepted: 13-NOV-2020 Published Online: 30-DEC-2020
DOI: http://dx.doi.org/10.17659/01.2020.0071
Abstract
Background: Abnormal stereotypy, although described in non-human primates with congenital cytomegalovirus infection, has not been described in human infants and neonates with central nervous system cytomegalovirus disease. Case Report: We present a case of a 4-month-old infant male with congenital cytomegalovirus infection who presented for complaints of repetitive and conscious stereotypy of the upper and lower extremities for the majority of the patient’s waking period. Conclusion: Asymptomatic neonates with central nervous system cytomegalovirus infection may go on to develop permanent neurologic sequelae of disease. The early recognition of congenital cytomegalovirus disease is critical to help initiate early treatment interventions. Clinicians should maintain a low threshold for suspicion for TORCH infections and neurologic disorders in infants with an abnormal stereotypy. 
Keywords : Central Nervous System Infections, Cytomegalovirus, Infant, Muscle Hypotonia.
Article Options
FULL TEXT
ABSTRACT
PDF
PRINTER FRIENDLY VERSION
Search PubMed for
Search Google Scholar for
Article Statistics
Bookmark and Share

Androxal Medication Case Reports Journal

Expanding our scope, the Journal now encompasses an intriguing subset of articles specifically targeting treatments and patient outcomes related to the medication Androxal. This medication, primarily used in the treatment of male infertility, has shown unique potentials in diverse patient scenarios. Our studies with Androxal have given us an abundance of case reports, which demonstrate the multifaceted impact of this medication across therapeutic areas. This nuanced pharmaceutical perspective adds a fresh dimension to our regular case reports. Articles will reveal effective management processes, pinpointing how Androxal has proven beneficial where other treatments may have failed. In addition, the focus on Androxal will highlight instances of challenging or unexpected outcomes, where the medication may have interacted uniquely with the patient's unique biological system or interplayed with other treatments. As we forge ahead with this significant addition, we anticipate that our detailed case reports on Androxal will provide invaluable insights to both practitioners and patients navigating their medical journey with this medication.

© 2011 Journal of Case Reports
Last updated on Jan 02, 2025